AlphaGrep UK Ltd’s Amgen AMGN Stock Holding History

AlphaGrep UK Ltd’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$281K	Buy	+800	New	+$285K	0.08%	545

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

AlphaGrep UK Ltd's AMGN Position: Q1 2026 in Review

AlphaGrep UK Ltd reduced its Amgen (AMGN) stake by 38% in Q1 2026, selling an estimated $158K and leaving 714 shares worth $251K. The position accounts for 0.07% of the portfolio, ranked #596.

AlphaGrep UK Ltd first reported a position in AMGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $379K in Q4 2025. 3,140 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

AlphaGrep UK Ltd held 714 shares of Amgen worth $251K as of Q1 2026.
AlphaGrep UK Ltd sold 444 Amgen shares in Q1 2026, an estimated $158K.
Amgen made up 0.07% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #596 holding.
AlphaGrep UK Ltd first reported a position in Amgen in Q4 2025 and has held it in 2 quarters since.
AlphaGrep UK Ltd's Amgen position peaked at $379K in Q4 2025.
3,140 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.